$26.37
-$0.22
(-0.83%)
Quote as of 12:08 PM EST on 02/10/12
Genomic Health
NASDAQ:GHDX
|
$26.37
|
|
| Today's Open | $26.49 |
|---|---|
| Previous Close | $26.59 |
| Daily Range | $25.90 - $26.50 |
| 52-Week Range | $19.00 - $29.52 |
| Market Cap | $779.03M |
| P/E Ratio | 102.27 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 54,151 |
| Average Daily Volume | 168,714 |
| Current FY EPS | $0.42 |
GHDX Information
| Description |
|---|
| Genomic Health's diagnostic tests offer innovative cancer screening. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Genomic Health Meets on Revenues, Misses on EPS
Genomic Misses, Grows Annually - Analyst Blog
Myriad Beats, Raises Guidance - Analyst Blog
Genomic's Useful Colon Cancer Test - Analyst Blog
Myriad Gets Rights to RAD51C Gene - Analyst Blog
Amass a Fortune With These Stocks
Genomic Looks to Diversify Offering (revised) - Analyst Blog
Genomic Looks to Diversify Offering - Analyst Blog
Myriad Reverts to Neutral - Analyst Blog
Ideas: 10 Stocks With Rising Gross Profit Margins and Insider Buying
